Trimethoprim/Sulfamethoxazole‐Induced Systemic Toxic Epidermal Necrolysis Syndrome: A Case Report
Clinical Case Reports · 2026-05 · 14 (5)
DOI: 10.1002/ccr3.72512 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 23.04.2026. Verfasst von Qing Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine Anhui Provincial Corps Hospital of the Chinese People's Armed Police Force Hefei Anhui Province China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Trimethoprim/sulfamethoxazole can induce life‐threatening toxic epidermal necrolysis. Early recognition, immediate drug cessation, and multidisciplinary supportive care are critical. Even with aggressive therapy, mortality remains high, and SCORTEN score aids in prognostication.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine Anhui Provincial Corps Hospital of the Chinese People's Armed Police Force Hefei Anhui Province China.
- Department of Gastroenterology Huangpu People's Hospital of Zhongshan City Zhongshan China.
ORCID-Profile: Qing Wang, Litong Chen, Wen Ye
Zitieren
APA
Wang, Q., Chen, L., & Ye, W. (2026). Trimethoprim/Sulfamethoxazole‐Induced Systemic Toxic Epidermal Necrolysis Syndrome: A Case Report. Clinical Case Reports, 14(5). https://doi.org/10.1002/ccr3.72512
Vancouver
Wang Q, Chen L, Ye W. Trimethoprim/Sulfamethoxazole‐Induced Systemic Toxic Epidermal Necrolysis Syndrome: A Case Report. Clinical Case Reports. 2026;14(5). doi:10.1002/ccr3.72512
BibTeX
@article{Wang2026,
author = {Wang, Qing and Chen, Litong and Ye, Wen},
title = {Trimethoprim/Sulfamethoxazole‐Induced Systemic Toxic Epidermal Necrolysis Syndrome: A Case Report},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {5},
doi = {10.1002/ccr3.72512}
}
EUVIMED